Literature DB >> 19364504

TNF-related apoptosis-inducing ligand suppresses PRDX4 expression.

Hua-Qin Wang1, Zhen-Xian Du, Bao-Qin Liu, Yan-Yan Gao, Xin Meng, Yifu Guan, Hai-Yan Zhang.   

Abstract

TNF-related apoptosis-inducing ligand (TRAIL) is currently considered a promising target for developing anti-cancer therapies. Accumulating evidences have now shown that oxidative stress is involved in the TRAIL-mediated cell death. The peroxiredoxins (PRDXs) are a ubiquitous family of proteins involved in protection against oxidative stress through the detoxification of cellular peroxides. Here we demonstrated that endogenous expression of PRDX4 was significantly decreased by TRAIL at the transcriptional level. In addition, overexpression of PRDX4 dramatically suppressed TRAIL-induced apoptosis. Taken together, these data for the first time suggested that TRAIL suppressed the PRDX4 gene at the transcriptional level and that downregulation of PRDX4 might facilitate cell death induced by TRAIL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364504     DOI: 10.1016/j.febslet.2009.04.009

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

Review 2.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

3.  Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Authors:  Anamika Basu; Hiya Banerjee; Heather Rojas; Shannalee R Martinez; Sourav Roy; Zhenyu Jia; Michael B Lilly; Marino De León; Carlos A Casiano
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

4.  The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer's disease.

Authors:  Andreas Schrötter; Kathy Pfeiffer; Fouzi El Magraoui; Harald W Platta; Ralf Erdmann; Helmut E Meyer; Rupert Egensperger; Katrin Marcus; Thorsten Müller
Journal:  Mol Cell Proteomics       Date:  2012-08-09       Impact factor: 5.911

5.  8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.

Authors:  Ylermi Soini; Kirsi-Maria Haapasaari; Markku H Vaarala; Taina Turpeenniemi-Hujanen; V Kärjä; Peeter Karihtala
Journal:  Int J Clin Exp Pathol       Date:  2011-03-02

6.  A proteomic approach for identification and localization of the pericellular components of chondrocytes.

Authors:  Zijun Zhang; Wu Jin; Jeffrey Beckett; Thomas Otto; Berton Moed
Journal:  Histochem Cell Biol       Date:  2011-06-23       Impact factor: 4.304

7.  The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia.

Authors:  Karishma K Palande; Renee Beekman; Lotte E van der Meeren; H Berna Beverloo; Peter J M Valk; Ivo P Touw
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

8.  Peroxiredoxin 4: a multifunctional biomarker worthy of further exploration.

Authors:  Janin Schulte
Journal:  BMC Med       Date:  2011-12-23       Impact factor: 8.775

9.  Genome-wide high-resolution aCGH analysis of gestational choriocarcinomas.

Authors:  Henriette Poaty; Philippe Coullin; Jean Félix Peko; Philippe Dessen; Ange Lucien Diatta; Alexander Valent; Eric Leguern; Sophie Prévot; Charles Gombé-Mbalawa; Jean-Jacques Candelier; Jean-Yves Picard; Alain Bernheim
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

10.  Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth.

Authors:  Tae Hyong Kim; Jieun Song; Sheila R Alcantara Llaguno; Eric Murnan; Sandya Liyanarachchi; Kamalakannan Palanichamy; Ji-Yeun Yi; Mariano Sebastian Viapiano; Ichiro Nakano; Sung Ok Yoon; Hong Wu; Luis F Parada; Chang-Hyuk Kwon
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.